FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

129474002: Caspofungin acetate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
208254011 Caspofungin acetate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
733610019 Caspofungin acetate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
15251000188114 caspofungine acétate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
798221000172113 acétate de caspofungine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Caspofungin acetate Is a Medicinal product containing echinocandin and acting as antifungal agent (product) false Inferred relationship Some
Caspofungin acetate Is a Echinocandin (substance) true Inferred relationship Some
Caspofungin acetate Is a classe d'allergènes false Inferred relationship Some
Caspofungin acetate Is a allergène médicamenteux false Inferred relationship Some
Caspofungin acetate Is a Caspofungin (substance) false Inferred relationship Some
Caspofungin acetate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antifungal true Inferred relationship Some
Caspofungin acetate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Caspofungin (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Caspofungin acetate 50mg powder for infusion solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Caspofungin acetate Inferred relationship Some
Caspofungin acetate 70mg powder for infusion solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Caspofungin acetate Inferred relationship Some
Caspofungin 70mg infusion concentrate (pdr for recon) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Caspofungin acetate Inferred relationship Some
Caspofungin 50mg infusion concentrate (pdr for recon) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Caspofungin acetate Inferred relationship Some
Caspofungin (as caspofungin acetate) 50 mg powder for solution for infusion vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Caspofungin acetate Inferred relationship Some 1
Product containing precisely caspofungin (as caspofungin acetate) 70 milligram/1 vial powder for conventional release solution for infusion (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Caspofungin acetate Inferred relationship Some 1

Reference Sets

US English

Back to Start